The bio-detection market is expected to experience growth, reaching a value of USD 12.27 billion from 2022 to 2027- 17000 + Technavio
Despite companies developing high-quality diagnostic technologies for chronic and infectious diseases, accessibility remains an issue in developing countries like India and China.
- Despite companies developing high-quality diagnostic technologies for chronic and infectious diseases, accessibility remains an issue in developing countries like India and China.
- This drive encompasses various technologies such as biosensors, immunoassays, molecular diagnostics, microarray technology, and lab-on-a-chip devices, among others, to bolster bio-detection capabilities worldwide.
- The observability platform market size is projected to increase by USD 1.17 billion, at a CAGR of 8.28% between 2023 and 2028.
- The c ustomer engagement solutions market size is estimated to grow at a CAGR of 10.8% between 2022 and 2027.